LISTSERV mailing list manager LISTSERV 16.5

Help for C-PALSY Archives

   

C-PALSY Archives

C-PALSY Archives


C-PALSY@LISTSERV.ICORS.ORG


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

C-PALSY Home

C-PALSY Home

C-PALSY  July 2012

C-PALSY July 2012

Subject:

Turning Skin Cells Into Brain Cells - 06/28/2012

From:

Meir Weiss <[log in to unmask]>

Reply-To:

Cerebral Palsy List <[log in to unmask]>

Date:

Mon, 2 Jul 2012 14:27:08 -0400

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (156 lines)

<http://www.hopkinsmedicine.org/news/media/releases/turning_skin_cells_into_
brain_cells>


More Sharing Services More 

 

Home > News and Publications > For the Media > Current News Releases







Turning Skin Cells Into Brain Cells



 Release Date: 06/28/2012 


Researchers create "Huntington's disease in a dish" to enable search for
treatment 



Johns Hopkins researchers, working with an international consortium, say
they have generated stem cells from skin cells from a person with a severe,
early-onset form of Huntington's disease (HD), and turned them into neurons
that degenerate just like those affected by the fatal inherited disorder.

By creating "HD in a dish," the researchers say they have taken a major step
forward in efforts to better understand what disables and kills the cells in
people with HD, and to test the effects of potential drug therapies on cells
that are otherwise locked deep in the brain.

Although the autosomal dominant gene mutation responsible for HD was
identified in 1993, there is no cure. No treatments are available even to
slow its progression.

The research, published in the journal Cell Stem Cell, is the work of a
Huntington's Disease iPSC Consortium, including scientists from the Johns
Hopkins University School of Medicine in Baltimore, Cedars-Sinai Medical
Center in Los Angeles and the University of California, Irvine, as well as
six other groups. The consortium studied several other HD cell lines and
control cell lines in order to make sure results were consistent and
reproducible in different labs.  

The general midlife onset and progressive brain damage of HD are especially
cruel, slowly causing jerky, twitch-like movements, lack of muscle control,
psychiatric disorders and dementia, and - eventually - death. In some cases
(as in the patient who donated the material for the cells made at Johns
Hopkins), the disease can strike earlier, even in childhood.

"Having these cells will allow us to screen for therapeutics in a way we
haven't been able to before in Huntington's disease," saysChristopher A.
Ross, M.D., Ph.D., a professor of psychiatry and behavioral sciences,
neurology, pharmacology and neuroscience at the Johns Hopkins University
School of Medicine and one of the study's lead researchers. "For the first
time, we will be able to study how drugs work on human HD neurons and
hopefully take those findings directly to the clinic."

Ross and his team, as well as other collaborators at Johns Hopkins and Emory
University, are already testing small molecules for the ability to block HD
iPSC degeneration.  These small molecules have the potential to be developed
into novel drugs for HD.

The ability to generate from stem cells the same neurons found in
Huntington's disease may also have implications for similar research in
other neurodegenerative diseases such as Alzheimer's and Parkinson's.

To conduct their experiment, Ross took a skin biopsy from a patient with
very early onset HD.  When seen by Ross at the HD Center at Hopkins, the
patient was just seven years old. She had a very severe form of the disease,
which rarely appears in childhood, and of the mutation that causes it. Using
cells from a patient with a more rapidly progressing form of the disease
gave Ross' team the best tools with which to replicate HD in a way that is
applicable to patients with all forms of HD.

Her skin cells were grown in culture and then reprogrammed by the lab of
Hongjun Song, Ph.D., a professor at Johns Hopkins' Institute for Cell
Engineering, into induced pluripotent stem cells. A second cell line was
generated in an identical fashion in Dr. Ross's lab from someone without HD.
Simultaneously, other HD and control iPS cell lines were generated as part
of the NINDS funded HD iPS cell consortium.

Scientists at Johns Hopkins and other consortium labs converted those cells
into generic neurons and then into medium spiny neurons, a process that took
three months. What they found was that the medium spiny neurons deriving
from HD cells behaved just as they expected medium spiny neurons from an HD
patient would. They showed rapid degeneration when cultured in the lab using
basic culture medium without extensive supporting nutrients. By contrast,
control cell lines did not show neuronal degeneration.  

"These HD cells acted just as we were hoping," says Ross, director of the
Baltimore Huntington's Disease Center. "A lot of people said, 'You'll never
be able to get a model in a dish of a human neurodegenerative disease like
this.' Now, we have them where we can really study and manipulate them, and
try to cure them of this horrible disease. The fact that we are able to do
this at all still amazes us."

Specifically, the damage caused by HD is due to a mutation in the huntingtin
gene (HTT), which leads to the production of an abnormal and toxic version
of the huntingtin protein. Although all of the cells in a person with HD
contain the mutation, HD mainly targets the medium spiny neurons in the
striatum, part of the brain's basal ganglia that coordinates movement,
thought and emotion. The ability to work directly with human medium spiny
neurons is the best way, researchers believe, to determine why these
specific cells are susceptible to cell stress and degeneration and, in turn,
to help find a way to halt progression of HD.

Much HD research is conducted in mice. And while mouse models have been
helpful in understanding some aspects of the disease, researchers say
nothing compares with being able to study actual human neurons affected by
HD.

For years, scientists have been excited about the prospect of making
breakthroughs in curing disease through the use of stem cells, which have
the remarkable potential to develop into many different cell types. In the
form of embryonic stem cells, they do so naturally during gestation and
early life. In recent years, researchers have been able to produce induced
pluripotent stem cells (iPSCs), which are adult cells (like the skin cells
used in Ross's experiments) that have been genetically reprogrammed back to
the most primitive state. In this state, under the right circumstances, they
can then develop into most or all of the 200 cell types in the human body.

The other members of the research consortium include the University of
Wisconsin School of Medicine, Massachusetts General Hospital and Harvard
Medical School, the University of California, San Francisco, Cardiff
University the Universita degli Studi diMilano and the CHDI Foundation.

Primary support for this research came from an American Recovery and
Reinvestment Act (ARRA) grant (RC2-NS069422) from the National Institutes of
Health's National Institute of Neurological Disorders and Stroke and a grant
from the CHDI Foundation, Inc.

Other Johns Hopkins researchers involved in this study include Sergey
Akimov, Ph.D.; Nicolas Arbez, Ph.D.; Tarja Juopperi, D.V.M., Ph.D.; Tamara
Ratovitski; Jason H. Chiang; Woon Roung Kim; Eka Chighladze, M.S., M.B.A.;
Chun Zhong; Georgia Makri; Robert N. Cole; Russell L. Margolis, M.D.; and
Guoli Ming, M.D., Ph.D.




For more information:
<http://neuroscience.jhu.edu/ChristopherRoss.php>

-----------------------

To change your mail settings or leave the C-PALSY list, go here:

http://listserv.icors.org/SCRIPTS/WA-ICORS.EXE?SUBED1=c-palsy

Top of Message | Previous Page | Permalink

Advanced Options


Options

Log In

Log In

Get Password

Get Password


Search Archives

Search Archives


Subscribe or Unsubscribe

Subscribe or Unsubscribe


Archives

December 2017
November 2017
November 2016
September 2016
August 2016
June 2016
May 2016
April 2016
March 2016
February 2016
December 2015
November 2015
October 2015
August 2015
July 2015
May 2015
April 2015
March 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
October 2004
September 2004
August 2004
July 2004
June 2004
May 2004
April 2004
March 2004
February 2004
January 2004
December 2003
November 2003
October 2003
September 2003
August 2003
July 2003
June 2003
May 2003
April 2003
March 2003
February 2003
January 2003
December 2002
November 2002
October 2002
September 2002
August 2002
July 2002
June 2002
May 2002
April 2002
March 2002
February 2002
January 2002
December 2001
November 2001
October 2001
September 2001
August 2001
July 2001
June 2001
May 2001
April 2001
March 2001
February 2001
January 2001
December 2000
November 2000
October 2000
September 2000
August 2000
July 2000
June 2000
May 2000
April 2000
March 2000
February 2000
January 2000
December 1999
November 1999
October 1999
September 1999
August 1999
July 1999
June 1999
May 1999
April 1999
March 1999
February 1999
January 1999
December 1998
November 1998
October 1998
September 1998
August 1998
July 1998
June 1998
May 1998
April 1998
March 1998
February 1998
January 1998
December 1997
November 1997
October 1997
September 1997
August 1997
July 1997
June 1997
May 1997
April 1997
March 1997
February 1997
January 1997

ATOM RSS1 RSS2



LISTSERV.ICORS.ORG

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager